Millennium Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Millennium Management’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-100,000	Closed	-$609K	–	4032
2016 Q4	$609K	Hold	100,000	–	–	﹤0.01%	2572
2016 Q3	$551K	Buy	+100,000	New	+$468K	﹤0.01%	2556
2015 Q3	–	Sell	-200,000	Closed	-$1.66M	–	3889
2015 Q2	$1.66M	Hold	200,000	–	–	﹤0.01%	2024
2015 Q1	$924K	Buy	+200,000	New	+$650K	﹤0.01%	2358

Other funds holding SGYP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

OCM

Opti Capital Management New York $1.64B AUM 0% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Millennium Management's SGYP Position: Q4 2018 in Review

Millennium Management sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2018, closing a stake of 12,504 shares — an estimated $21K sold.

Millennium Management first reported a position in SGYP in Q2 2013 and held it in 21 quarters. The position peaked at $19.2M in Q2 2015. 89 funds tracked by Wall St. Rank hold SGYP as of Q4 2018.

Millennium Management reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2018 after selling out during the quarter.
Millennium Management sold 12,504 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2018, an estimated $21K.
Millennium Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 21 quarters.
Millennium Management's Synergy Pharmaceuticals, Inc Common Stock position peaked at $19.2M in Q2 2015.
89 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2018.

Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.